Agenda

The agenda is being continuously updated, please check back for speaker updates.

The Westin Boston Seaport District
425 Summer Street, Boston, MA 02210

7:30–8:15 Breakfast

8:15–8:30 Welcome: Introduction to MedExecWomen

8:30–9:00 Opening Keynote

What do Leading Physicians Think are the Most Innovative Trends in Medtech?

Moderated by: Heather Knight, EVP and Group President, Baxter

• Ami Bhatt, MD, Chief Innovation Officer, American College of Cardiology

• Miho Tanaka, MD, Director, Women's Sports Medicine Program, MGH | Head Team Physician, New England Revolution | Team Physician: Boston Red Sox, Boston Ballet, Boston Glory

The opening keynote is a Fireside Chat to discuss where innovation is taking medtech and the strategies that should be a part of all of our technology development programs. Don’t miss this kick-off keynote presentation with these three extraordinary women!

9:00–10:00 Panel 1

Powerful Tools to Unleash Patient-Centric Innovation

Moderated by: Elena Pretto, Partner, Life Science, Strategy& (PwC)

• Liza Davis, VP, Product Development, Endoscopy, Boston Scientific

• Masha Dumanis, Vice President, Health Advances

• Trang Ly, MBBS, Senior Vice President and Medical Director, Insulet

• Kathleen O'Donnell, VP Marketing, New Business Development, Lifeward

How do we merge a rigorous and deep understanding of disease treatment with the needs and experience of the patient, health care practitioner, and caregiver to deliver life-changing innovations?

10:00–10:30 Break

10:30–11:30     Panel 2

Bridging Regulatory & Reimbursement Strategies for Success

Moderated by: Anne Smart, Principal, Head of Strategy & Portfolio Development, Medtech, ZS

• Lori Fontaine, VP Global Clinical Strategy Orthopedics/Sports Medicine & ENT, Smith & Nephew

• Kanchana Iyer , Senior Consultant, Regulatory Affairs, Halloran Consulting Group

• Jenny Levinson, Global VP, Health Economics & Market Access, Boston Scientific

• Christy Sheehy, CEO/Founder, C Light Technologies

Regulatory and reimbursement strategies are changing to provide great benefit to the medtech world. How can we find innovative solutions to navigate the complex regulatory and reimbursement landscape and create streamlined approaches for faster market access?

11:30–12:45 Breakout Sessions

All attendees will participate in both sessions.

• Session 1: Innovative Medtech Collaborations, Partnerships and Alliances With Traditional and Non-Traditional Partners

  As the Medtech landscape continues to evolve, understanding the dynamics of collaborations with non-traditional partners becomes essential for industry stakeholders. This breakout will tackle the strategies, benefits, and challenges associated with innovative Medtech collaborations with non-traditional partners.

  Moderated by: Maria Shepherd, President, Medi-Vantage

  • Jiny Kim, Senior Vice President, Solta Medical, Global, Bausch Health Companies Inc.

  • Jayme Lorentz, WW Vice President, Marketing Technology & Data Solutions, Zimmer Biomet

• Session 2: Staying Ahead of the Curve - Training & Education Strategies

  What innovative strategies can ensure that team members are up-to-date with the latest advancements and can integrate them into their plans? How can AI and machine learning be applied to customize training programs for different roles in an organization?

  • Heather Cannon,VP, Medtech Education, DePuy Synthes

  • Melvaleen Steward, Global Vice President, Core Portfolio and Innovation, Alcon

12:45–1:45      Lunch

1:45–2:30     Executive Interview

Interview with Ashley McEvoy, Former EVP & Worldwide Chairman of MedTech, Johnson & Johnson | Current Member of the Board of Directors, Procter & Gamble

Interviewed by: Martha Shadan, Medtech CEO & Board Member

Ashley McEvoy is a top Fortune 50 executive and board member with nearly three decades’ experience creating transformational change in health care. She is highly regarded for her track record of driving growth and innovation across Johnson & Johnson and leading many of its most important businesses, as well as her visionary, human centric leadership and passion for improving patient lives.

As the former Executive Vice President and Worldwide Chairman of Johnson & Johnson’s MedTech division, Ashley led an organization with 60,000 global employees and revenue of more than $30 billion in 2023. Prior to leading MedTech, Ashley served as Johnson & Johnson’s Group Chairman, Consumer Medical Devices; Group Chairman, Vision Care; Worldwide President, Ethicon Products; President, McNeil Consumer Healthcare; and held a number of management, marketing and brand management roles in OTC and other consumer health care.

Ashley currently serves on the Board of Directors of Procter & Gamble as well as the Board of Trustees for the internationally renowned Children’s Hospital of Philadelphia (CHOP). She has been named to several prestigious lists including FORTUNE’s “Future Fortune 500 CEOs,” Forbes’ inaugural “CEO NEXT” list, and in 2019 was named to FORTUNE’S Most Powerful Women list. 

2:30–3:30      Panel 3

Beyond the Hospital: A Revolution in Digital, Telehealth, and Retail Solutions

Moderated by: Stephanie Wimmer, Global Vice President, Health Economics, Philips

• Aline Criton, Chief Medical Officer, Withings

• Janet Dillione, CEO, Connect America

• Shelly Ikeme, North America Head of Health Economics & Market Access, J&J Medtech

• Julia Strandberg, Chief Business Leader, Connected Care & Monitoring, Philips

As the needs of patients and providers evolve and the cost of health care increases, patient care continues to migrate outside of the expensive bricks and mortar of hospitals. In this session we will explore how new digital, telehealth, and retail solutions adapt to the changing healthcare environment paying specific attention to how the efficiency and effectiveness of these solutions will be demonstrated with evidence and how they are reimbursed by payers.

3:30–4:00      Break

4:00–5:00      Panel 4

Innovative Approaches To Using Data, Analytics, AI and Machine Learning

Moderated by: Meghna Eichelberger, Partner and Associate Director, Medical Technologies, BCG

• Tobi Karchmer, MD, Chief Medical and Scientific Officer, Baxter

• Diana Nole, CVP Microsoft Health & Life Sciences | EVP and GM, Nuance Healthcare Division, Nuance/Microsoft

• Ruchika Singhal, President, Medtronic Labs

In the dynamic landscape of MedTech, harnessing data, analytics, AI, and machine learning is no longer a choice—it’s an imperative. This session will delve into the transformative power of these technologies in shaping patient outcomes across the entire lifecycle of healthcare companies.

5:00–6:30       Closing Debate with Networking Wine Reception

Mars vs. Venus - Gender Differences in Driving Innovation

Moderated by: Leslie Storms, U.S. President, DePuy Synthes

• Cheryl Blanchard, President & CEO, Anika Therapeutics

• Nadim Yared, Chairman of the Board, NAMSA

In this unique one-on-one "debate," featuring a male and female medtech executive, we will explore the importance of diversity in fostering innovation, and discuss where there may be differences between male and female leaders in their ability to drive an innovative culture.